Diadema Partners LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $383 Billion distributed in 102 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Regeneron Pharmaceuticals, Inc. with a value of $18.9B, Eli Lilly & CO with a value of $15.9B, Jazz Pharmaceuticals PLC with a value of $10.8B, Tg Therapeutics, Inc. with a value of $8.2B, and Argenx Se with a value of $7.18B.

Examining the 13F form we can see an increase of $150B in the current position value, from $233B to 383B.

Diadema Partners LP is based out at Morristown, NJ

Below you can find more details about Diadema Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $383 Billion
Healthcare: $331 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 102
  • Current Value $383 Billion
  • Prior Value $233 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 20 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.